| scholarly article | Q13442814 |
| P50 | author | Laurence Zitvogel | Q28317098 |
| Clara Locher | Q40775267 | ||
| Nathalie Chaput | Q37282462 | ||
| Sylvie Rusakiewicz | Q37284788 | ||
| P2093 | author name string | Mélanie Desbois | |
| P2860 | cites work | Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA | Q22010440 |
| ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor | Q24290906 | ||
| Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids | Q24297055 | ||
| Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium | Q24318429 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire | Q28189785 | ||
| Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 | ||
| HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C | Q28263511 | ||
| A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
| Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin | Q28476707 | ||
| Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function | Q28854563 | ||
| Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma | Q30422102 | ||
| Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. | Q31775425 | ||
| Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells | Q33292289 | ||
| Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. | Q33292532 | ||
| Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool | Q33305767 | ||
| Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. | Q33405958 | ||
| Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients | Q33621891 | ||
| Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells | Q33641266 | ||
| The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype | Q33674720 | ||
| Regulation of human NK-cell cytokine and chemokine production by target cell recognition. | Q33747309 | ||
| Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity | Q37509338 | ||
| Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity | Q37552151 | ||
| Epithelial-mesenchymal transition in hepatocellular carcinoma. | Q37620382 | ||
| Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease | Q37729217 | ||
| Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells | Q37919352 | ||
| Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells | Q37948886 | ||
| The role of cancer stem cells in relapse of solid tumors | Q37971690 | ||
| Targeting natural killer cells and natural killer T cells in cancer | Q37995950 | ||
| Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients. | Q38421050 | ||
| Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. | Q39321728 | ||
| Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer | Q39321788 | ||
| Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition | Q39470152 | ||
| IRF-1 expression is essential for natural killer cells to suppress metastasis. | Q39477832 | ||
| IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice | Q39516441 | ||
| Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors | Q39546314 | ||
| Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. | Q39723501 | ||
| Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction | Q39984066 | ||
| Expression of ligands to NKp46 in benign and malignant melanocytes. | Q40059638 | ||
| Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity | Q40323654 | ||
| A novel dendritic cell subset involved in tumor immunosurveillance | Q40323661 | ||
| Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. | Q40465512 | ||
| Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. | Q40528376 | ||
| The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic | Q40597320 | ||
| MICA/NKG2D-mediated immunogene therapy of experimental gliomas. | Q40604072 | ||
| Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses | Q40908512 | ||
| Receptors for HLA class-I molecules in human natural killer cells. | Q41039762 | ||
| Granulated lymphocytes of pregnancy | Q41209172 | ||
| Role of NK cells in tumour growth and metastasis in beige mice | Q41643296 | ||
| Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. | Q42360336 | ||
| Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis | Q42457329 | ||
| Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin | Q42604162 | ||
| The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells | Q43292337 | ||
| NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. | Q43562662 | ||
| NK cell regulation of CD4 T cell-mediated graft-versus-host disease. | Q44334672 | ||
| Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes. | Q44427177 | ||
| NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases | Q44483781 | ||
| Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients | Q46058156 | ||
| Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense | Q46197286 | ||
| NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. | Q47225487 | ||
| Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice | Q47661031 | ||
| CD27 defines phenotypically and functionally different human NK cell subsets. | Q49167535 | ||
| Maturation of mouse NK cells is a 4-stage developmental program. | Q50602171 | ||
| Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. | Q50753300 | ||
| In vivo developmental stages in murine natural killer cell maturation. | Q52120129 | ||
| Innate and adaptive lymphoid cells in the human liver | Q33916563 | ||
| Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population | Q33928216 | ||
| The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. | Q34152180 | ||
| The biology of human natural killer-cell subsets | Q34430869 | ||
| Heparan sulfate proteoglycans and cancer. | Q34441253 | ||
| Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation | Q34490829 | ||
| Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. | Q34632699 | ||
| Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity | Q35208414 | ||
| Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. | Q35572366 | ||
| Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. | Q35753251 | ||
| Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host | Q35828703 | ||
| NK cells and trophoblasts: partners in pregnancy | Q35921864 | ||
| The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. | Q36131712 | ||
| Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. | Q36184983 | ||
| CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells | Q36229123 | ||
| Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells | Q36231015 | ||
| Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage | Q36267204 | ||
| Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism | Q36351357 | ||
| Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma | Q36368808 | ||
| Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success | Q36399286 | ||
| TLR-dependent cross talk between human Kupffer cells and NK cells | Q36446960 | ||
| NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy | Q36484325 | ||
| Organ-specific features of natural killer cells | Q36750759 | ||
| CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis | Q36882248 | ||
| Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells | Q36903104 | ||
| NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. | Q37170785 | ||
| Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. | Q37229927 | ||
| PCNA on the crossroad of cancer | Q37482167 | ||
| Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells | Q37484974 | ||
| A novel orthotopic model of breast cancer metastasis to bone. | Q52826484 | ||
| NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice. | Q53017182 | ||
| H₂O₂ production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction. | Q53228298 | ||
| Immune cells in primary gastrointestinal stromal tumors. | Q53323320 | ||
| Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model. | Q53348217 | ||
| High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. | Q53383813 | ||
| Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. | Q53437765 | ||
| Application of CD27 as a marker for distinguishing human NK cell subsets. | Q53493736 | ||
| Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. | Q53985486 | ||
| Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. | Q54432520 | ||
| Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. | Q54688363 | ||
| The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. | Q54723187 | ||
| Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma | Q56965815 | ||
| Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones | Q57186398 | ||
| Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape | Q57272360 | ||
| Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells | Q57556316 | ||
| NK dendritic cells are innate immune responders to Listeria monocytogenes infection | Q58034326 | ||
| A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127 | Q58478714 | ||
| TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver | Q60489511 | ||
| Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection | Q60489553 | ||
| Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation | Q61483544 | ||
| NK cells promote islet allograft tolerance via a perforin-dependent mechanism | Q63363306 | ||
| The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes | Q70289866 | ||
| Role of NK cells in the control of metastatic spread and growth of tumor cells in mice | Q70452698 | ||
| Origin and differentiation of hepatic natural killer cells (pit cells) | Q70496872 | ||
| Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo | Q73850203 | ||
| The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma | Q73954534 | ||
| Expression of stress-induced MHC class I related chain molecules on human melanoma | Q77834581 | ||
| Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity | Q78469598 | ||
| The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues | Q79484960 | ||
| Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells | Q80510655 | ||
| Natural killer cells infiltrating colorectal cancer and MHC class I expression | Q81165432 | ||
| Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12 | Q81434882 | ||
| Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance | Q82193347 | ||
| CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity | Q82310845 | ||
| Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases | Q82533270 | ||
| Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance | Q82878964 | ||
| Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines | Q83420653 | ||
| Melanoma cells inhibit NK cell functions | Q87420090 | ||
| P304 | page(s) | 395 | |
| P577 | publication date | 2012-12-24 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Natural killer cells in non-hematopoietic malignancies | |
| P478 | volume | 3 |
| Q58787920 | Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy |
| Q64915364 | Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients. |
| Q33703214 | Licensing delineates helper and effector NK cell subsets during viral infection |
| Q26991949 | NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma |
| Q34933101 | NK cells and T cells cooperate during the clinical course of colorectal cancer |
| Q54369697 | NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. |
| Q64102223 | NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment |
| Q37616478 | NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients |
| Q35743162 | Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentia |
| Q38860610 | Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors |
| Q37222064 | Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients. |
| Q37228973 | Prolonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors. |
| Q37171499 | Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage. |
Search more.